Viewing nowCombinationTeloditan Tablet 40/10mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ilhwa Co., Ltd.

MFDS item code 201702541 · Approved 2017.05.24 · Insurance code 640903430
Improvement in blood pressure control for essential hypertension
This drug is used to effectively lower and control blood pressure in patients with primary hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or telmisartan.
The recommended dosage for this drug is one tablet once a day, taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients with mild to moderate renal impairment, dosage adjustments are not necessary; however, in patients with severe renal impairment, treatment should be initiated at a lower dose and increased slowly. For patients with mild to moderate liver impairment,
The safety and efficacy of this drug in pediatric patients under the age of 18 have not been established, and therefore the use of this drug is not recommended.
This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should not be taken by women who are pregnant or may become pregnant. This drug should not be administered to patients with certain conditions, for example, those with an allergy to the components of this drug, severe liver disease, low blood pressure, or severe heart disease should avoid taking it. In some patients, this drug should be used with caution, such as in patients with liver disease, gastrointestinal disorders, renal impairment, and the elderly, who should take it under careful observation of a physician. Common side effects of this drug may include dizziness or peripheral edema, and serious side effects can occur rarely; if abnormal symptoms appear, you should immediately consult healthcare professionals. It is important not to use this drug during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible and replaced with another safe treatment. There is a risk of low blood pressure, so patients who are deficient in fluids or salt should improve their condition before taking and closely monitor blood pressure changes during use. This drug can affect blood potassium levels, so patients at risk of hyperkalemia should have regular blood tests and exercise caution when taken with potassium supplements or potassium-containing medications. In patients with renal impairment, regular blood tests and monitoring of kidney function are essential to prevent deterioration of kidney function. Patients with heart disease may have an increased risk of angina or myocardial infarction while taking this drug, so they should be alert to changes in symptoms. This drug may cause drowsiness or dizziness, so caution is needed when driving or operating machinery. This drug can interact with other medications; therefore, if you are taking other medications, you must inform your physician or pharmacist, and especially avoid caution when taking it with certain heart medications, diuretics, potassium supplements, and anti-inflammatory drugs. Women who are breastfeeding are advised not to take this drug; if necessary, consultation with a physician is required. In case of overdose, symptoms such as low blood pressure, dizziness, and heart dysfunction may occur; immediate emergency treatment from healthcare professionals is necessary. The safety and efficacy of this drug in children have not been adequately established, so it is not recommended.
Hives, severe swelling (edema), cold sweat, pallor, severe allergic reactions, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory difficulties accompanied by cough and fever, jaundice, liver abnormalities, sudden and very severe headache, lightning headaches, seizures, confusion of consciousness, visual disturbances, paralysis, serious neurological symptoms, decreased urine output
Dizziness, peripheral edema, upper respiratory tract infection, pharyngitis, sinusitis, urinary tract infection, cystitis, anemia, thrombocytopenia, eosinophilia, depression, insomnia, mood changes, anxiety, drowsiness, headache, sensory disturbances, taste disturbances, tremors, visual disturbances, lightheadedness, tinnitus, palpitations, bradycardia, tachycardia, flushing, hypotension, orthostatic hypotension, cough, gastrointestinal adverse reactions (abdominal pain, diarrhea, nausea, vomiting, dyspepsia, dry mouth, gingival hyperplasia, abdominal discomfort
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light; it should be stored in a container that blocks light. It is also recommended to store the medication at room temperature between 1 degree and 30 degrees Celsius. This storage method will maintain the effectiveness of the medication and ensure safe use.
Biconvex oval double tablet, white and light gray
30 tablets/box [10 tablets/Alu-Alu X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.